ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS
First Claim
1. A diabetes management system comprising:
- an analyte measurement device including;
a housing;
a processor and memory disposed in the housing;
a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids;
a display in communication with the processor to display information relating to analyte and the therapeutic agent;
a first wireless module coupled to the processor and memory to store data received by the first wireless module in the memory;
a therapeutic agent delivery device including;
a delivery device housing;
a delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider;
a second wireless module disposed in the housing, the second wireless module being configured to automatically, without prompting or any action from a user, transmits a signal to the first wireless module indicative of;
(a) type of therapeutic agent delivered; and
(b) amount of therapeutic agent delivered to the user;
or(c) type of therapeutic agent device from which the therapeutic agent was administered.
0 Assignments
0 Petitions
Accused Products
Abstract
Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.
-
Citations
35 Claims
-
1. A diabetes management system comprising:
-
an analyte measurement device including; a housing; a processor and memory disposed in the housing; a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids; a display in communication with the processor to display information relating to analyte and the therapeutic agent; a first wireless module coupled to the processor and memory to store data received by the first wireless module in the memory; a therapeutic agent delivery device including; a delivery device housing; a delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider; a second wireless module disposed in the housing, the second wireless module being configured to automatically, without prompting or any action from a user, transmits a signal to the first wireless module indicative of; (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user;
or(c) type of therapeutic agent device from which the therapeutic agent was administered. - View Dependent Claims (6, 7, 8, 10, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
-
-
2. A diabetes management system comprising:
-
an analyte measurement device including; a housing; a processor and memory disposed in the housing; a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids; a display in communication with the processor to display information relating to analyte and the therapeutic agent; a first wireless module coupled to the processor and memory to store data received by the first wireless module in the memory; a therapeutic agent delivery device including; a delivery device housing; a delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider; a second wireless module disposed in the housing and coupled to the delivery mechanism, the second wireless module, upon prompting or by an action from a user, transmits a signal to the first wireless module indicative of; (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user;
or(c) type of therapeutic agent device from which the therapeutic agent was administered; and a health care provider computer in communication with the analyte measurement device to prescribe one of a plurality of therapeutic agent titration protocols to the memory of the analyte measurement device.
-
-
3. A diabetes management device comprising:
-
a housing; a processor and memory disposed in the housing, the memory including a plurality of therapeutic administration protocols loaded into the memory from an external source that relates a dosage administration to one or more analyte amount; a measurement unit in communication with the processor to provide a numerical value representing generally an amount of analyte in body fluids; a display in communication with the processor to display information relating to measured amount of analyte and type of therapeutic agent from the plurality of protocols. - View Dependent Claims (4, 5, 9)
-
-
28. A method of managing diabetes of a user, the method comprising:
-
selecting a therapeutic administration protocol in accordance with therapeutic requirements of the diabetic user; transferring the therapeutic administration protocol to an analyte measurement device assigned to the user; confirming delivery of therapeutic agent to the user in accordance with the therapeutic administration protocol; and generating a plurality of prompts to the user including; (a) a reminder to measure analyte at a specified time; (b) a reminder to administer a recommended dosage of therapeutic agent within a specified time frame; and (c) a report of compliance of the user to the therapeutic administration protocol. - View Dependent Claims (29, 30, 31, 32)
-
-
33. A method of operating an analyte measurement device having a plurality of therapeutic administration protocols stored in a memory of the device, the memory in communication with a processor, the processor configured to interface with user inputs and provide various output information, the method comprising:
-
accessing a selection menu generated by the processor with protocols loaded into the memory from an external source; selecting one therapeutic administration protocol from the plurality of therapeutic administration protocols; and outputting dosage information for therapeutic agent to be administered to a user based on one or multiple analyte amounts or concentration values stored in the memory. - View Dependent Claims (34, 35)
-
Specification